General Information of the Compound
Compound ID
CP0064592
Compound Name
[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
    Show/Hide
Synonyms
Benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester, (2aR-(2aalpha,4beta,4abeta,6beta,9alpha(alphaR*,betaS*),11alpha,12alpha,12aalpha,12balpha))-
C47H51NO14
Micellar Paclitaxel
Paclitaxel [USAN:INN:BAN]
SCHEMBL15000506
Taxol
weekly paclitaxel
    Show/Hide
Structure
Formula
C47H51NO14
Molecular Weight
853.918
Canonical SMILES
CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)c3ccccc3)[C@@H]3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C1=O)OC(C)=O)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)c1ccccc1)c1ccccc1
    Show/Hide
InChI
InChI=1S/C47H51NO14/c1-25-31(60-43(56)36(52)35(28-16-10-7-11-17-28)48-41(54)29-18-12-8-13-19-29)23-47(57)40(61-42(55)30-20-14-9-15-21-30)38-45(6,32(51)22-33-46(38,24-58-33)62-27(3)50)39(53)37(59-26(2)49)34(25)44(47,4)5/h7-21,31-33,35-38,40,51-52,57H,22-24H2,1-6H3,(H,48,54)/t31-,32-,33+,35-,36+,37+,38-,40-,45+,46-,47+/m0/s1
    Show/Hide
InChIKey
RCINICONZNJXQF-MZXODVADSA-N
CAS
33069-62-4
Physicochemical Property
logP
3.7357
Rotatable Bonds
10
Heavy Atom Count
62
Polar Areas
221.29
Hydrogen Bond Donor Count
4
Hydrogen Bond Acceptor Count
14
Complexity
62

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 36314
SID: 14767269
ChEMBL ID
CHEMBL428647
DrugBank ID
DB01229
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01216, Apoptosis regulator Bcl-2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000001 Jurkat Homo sapiens (Human)  1
1
GI50 > 10000 nM
   TI
   LI
   LO
   TS
Protein ID: PT01546, ATP-dependent translocase ABCB1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000084 SK-OV-3 Homo sapiens (Human)  1
1
IC50 = 2596 nM
   TI
   LI
   LO
   TS
CL000167 NIH-3T3-G185 Mus musculus (Mouse)  3
1
IC50 = 53900 nM
   TI
   LI
   LO
   TS
2
IC50 = 54000 nM
   TI
   LI
   LO
   TS
3
IC50 = 70200 nM
   TI
   LI
   LO
   TS
CL000013 Sf9 Spodoptera frugiperda (Fall armyworm)  1
1
Km = 700 nM
   TI
   LI
   LO
   TS
Protein ID: PT01217, Bcl-2-like protein 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000001 Jurkat Homo sapiens (Human)  1
1
GI50 > 10000 nM
   TI
   LI
   LO
   TS
Protein ID: PT04542, Bile salt export pump
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000013 Sf9 Spodoptera frugiperda (Fall armyworm)  1
1
IC50 = 24400 nM
   TI
   LI
   LO
   TS
CL000757 SK-E2 Homo sapiens (Human)  2
1
IC50 = 26800 nM
   TI
   LI
   LO
   TS
2
IC50 = 28900 nM
   TI
   LI
   LO
   TS
Protein ID: PT06109, Geminin
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000015 SW480 Homo sapiens (Human)  2
1
Potency ~ 9.2 nM
   TI
   LI
   LO
   TS
2
Potency ~ 168.9 nM
   TI
   LI
   LO
   TS
Protein ID: PT01065, Serine/threonine-protein kinase mTOR
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL001056 MEF-1 [Mouse fibroblast] Mus musculus (Mouse)  1
1
Potency = 369 nM
   TI
   LI
   LO
   TS
Protein ID: PT06540, Tubulin beta-3 chain
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  2
1
IC50 = 7.7 nM
   TI
   LI
   LO
   TS
2
IC50 = 9.2 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000001 Jurkat Homo sapiens (Human)  1
1
GI50 < 10 nM
   TI
   LI
   LO
   TS
CL000002 K-562 Homo sapiens (Human)  1
1
GI50 = 6.3 nM
   TI
   LI
   LO
   TS
CL000007 HT-29 Homo sapiens (Human)  1
1
GI50 = 5 nM
   TI
   LI
   LO
   TS
CL000017 HeLa Homo sapiens (Human)  1
1
IC50 = 1.6 nM
   TI
   LI
   LO
   TS
CL000048 PC-3 Homo sapiens (Human)  1
1
GI50 = 6.3 nM
   TI
   LI
   LO
   TS
CL000068 A-549 Homo sapiens (Human)  1
1
GI50 = 6.3 nM
   TI
   LI
   LO
   TS
CL000078 T-47D Homo sapiens (Human)  1
1
GI50 = 12.5 nM
   TI
   LI
   LO
   TS
CL000084 SK-OV-3 Homo sapiens (Human)  1
1
IC50 = 4.4 nM
   TI
   LI
   LO
   TS
CL000104 SW620 Homo sapiens (Human)  1
1
GI50 = 4 nM
   TI
   LI
   LO
   TS
CL000111 MDA-MB-231 Homo sapiens (Human)  1
1
GI50 = 12.5 nM
   TI
   LI
   LO
   TS
CL000116 MOLT-4 Homo sapiens (Human)  1
1
GI50 = 5 nM
   TI
   LI
   LO
   TS
CL000145 NCI-H460 Homo sapiens (Human)  1
1
GI50 = 6.3 nM
   TI
   LI
   LO
   TS
CL000163 COLO 205 Homo sapiens (Human)  1
1
GI50 = 7.9 nM
   TI
   LI
   LO
   TS
CL000212 Malme-3M Homo sapiens (Human)  1
1
GI50 = 50 nM
   TI
   LI
   LO
   TS
CL000244 786-O Homo sapiens (Human)  1
1
GI50 = 39 nM
   TI
   LI
   LO
   TS
CL000313 SK-MEL-28 Homo sapiens (Human)  1
1
GI50 = 400 nM
   TI
   LI
   LO
   TS
CL000365 NCI-H226 Homo sapiens (Human)  1
1
GI50 = 3.9 nM
   TI
   LI
   LO
   TS
CL000619 SK-MEL-2 Homo sapiens (Human)  1
1
GI50 = 400 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Taxol )
Drug Name Taxol
Indication
Breast cancer
Approved
Solid tumour/cancer
Phase 3
Breast cancer
Phase 2
Pancreatic cancer
Phase 2
Solid tumour/cancer
Phase 2
Gastric adenocarcinoma
Phase 2
Ovarian cancer
Phase 2
Target(s)
Apoptosis regulator Bcl-2 (BCL-2)
Modulator